338
Participants
Start Date
November 28, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
DE-117B Eye Drops
Investigational Product: 0.002% DE-117B Eye Drops
Latanoprost
Active Control: 0.005% Latanoprost Eye Drops
NOT_YET_RECRUITING
Beijing Chao-Yang Hospital, Capital Medical University, Beijing
RECRUITING
Beijing Hospital, Beijing
RECRUITING
Beijing Tongren Hospital, Capital Medical University, Beijing
NOT_YET_RECRUITING
Peking University Third Hospital, Beijing
RECRUITING
Zhongshan Ophthalmic Center, Guangzhou
RECRUITING
Affiliated Hospital of Guizhou Medical University, Guiyang
RECRUITING
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
RECRUITING
Zhejiang Provincial People's Hospital, Hangzhou
RECRUITING
Jinan Second People's Hospital (Jinan eye hospital), Jinan
RECRUITING
The Second Hospital & Clinical Medicial Lanzhou University, Lanzhou
RECRUITING
Luoyang third people's hospital, Luoyang
NOT_YET_RECRUITING
Qingdao Eye Hospital of Shandong First Medical University, Qingdao
RECRUITING
Shanghai Eye Disease Prevention And Treatment Center/Shanghai Eye Hospital, Shanghai
RECRUITING
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong, Shantou
RECRUITING
Shanxi eye hospital, Shanxi
RECRUITING
Aier Eye Hospital (Liaoning), Shenyang
RECRUITING
The 4th People's Hospital of Shenyang, Shenyang
RECRUITING
Shenzhen Eye Hospital, Shenzhen
RECRUITING
Tianjin Eye Hospital, Tianjin
RECRUITING
Weifang Eye Hospital, Weifang
RECRUITING
Wuhan Aier Eye Hospital, Wuhan
RECRUITING
Wuhan Puren Hospital, Wuhan
RECRUITING
Zhongnan Hospital Affiliated to Wuhan University, Wuhan
RECRUITING
Wuxi Second People's Hospital, Wuxi
RECRUITING
Xiamen Eye Centre of Xiamen University Co., Ltd., Xiamen
Santen Pharmaceutical Co., Ltd.
INDUSTRY